Breaking News Instant updates and real-time market news.

2020-04-22 12:00:51 LB L Brands $9.55 / -2.5 (-20.75%) 12:00 04/22/20 04/22 12:00 04/22/20 12:00	L Brands falls -20.6% L Brands is down -20.6%, or -$2.49 to $9.57.	14 May 21 May
LB L Brands $9.55 / -2.5 (-20.75%) 04/15/20 RBC Capital L Brands price target lowered to $14 from $24 at RBC Capital 03/24/20 Citi L Brands price target lowered to $9 from $20 at Citi 03/20/20 Deutsche Bank L Brands price target lowered to $24 from $29 at Deutsche Bank 03/19/20 Morgan Stanley Morgan Stanley lowers targets for Gap, Macy's, and four other levered retailers

2020-04-22 12:00:51

L Brands

$9.55 / -2.5 (-20.75%)

12:00

04/22/20

04/22

12:00

04/22/20

12:00

L Brands falls -20.6%

L Brands is down -20.6%, or -$2.49 to $9.57.

14
May
21
May

LB L Brands

$9.55 / -2.5 (-20.75%)

04/15/20 RBC Capital: L Brands price target lowered to $14 from $24 at RBC Capital

03/24/20 Citi: L Brands price target lowered to $9 from $20 at Citi

03/20/20 Deutsche Bank: L Brands price target lowered to $24 from $29 at Deutsche Bank

03/19/20 Morgan Stanley: Morgan Stanley lowers targets for Gap, Macy's, and four other levered retailers

TODAY'S FREE FLY STORIES

Upgrade	HarborOne Bancorp upgraded to Buy from Neutral at DA Davidson » 07:20 03/05/21 03/05 07:20 03/05/21 07:20 HONE HarborOne Bancorp $12.77 / -0.145 (-1.12%) DA Davidson analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings HONE HarborOne Bancorp $12.77 / -0.145 (-1.12%) 02/19/21 Piper Sandler HarborOne Bancorp downgraded to Neutral from Overweight at Piper Sandler 06/16/20 DA Davidson HarborOne Bancorp initiated with a Neutral at DA Davidson 06/15/20 DA Davidson HarborOne Bancorp initiated with a Neutral at DA Davidson HONE HarborOne Bancorp $12.77 / -0.145 (-1.12%) 01/28/21 HarborOne Bancorp reports Q4 EPS 33c, consensus 22c 10/27/20 HarborOne Bancorp reports Q3 EPS 22c, consensus 17c
General news	European stock markets are mostly lower » 07:20 03/05/21 03/05 07:20 03/05/21 07:20 European stock markets… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
General news	FX Update: The dollar has continued to ascend » 07:20 03/05/21 03/05 07:20 03/05/21 07:20 FX Update: The dollar has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Broadcom price target raised to $460 from $450 at RBC Capital » 07:19 03/05/21 03/05 07:19 03/05/21 07:19 AVGO Broadcom $443.23 / -19.235 (-4.16%) RBC Capital analyst Mitch… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AVGO Broadcom $443.23 / -19.235 (-4.16%) 03/04/21 Broadcom CFO says delivered about $3B in free cash flow in Q1 02/22/21 ForeScout appoints Kevin O'Leary chief product officer 12/21/20 Broadcom CEO sells over 14,000 common shares 12/16/20 Synnex awarded commercial aggregator agreement with Broadcom AVGO Broadcom $443.23 / -19.235 (-4.16%) 06:59 Today Wells Fargo Broadcom price target raised to $450 from $410 at Wells Fargo 06:46 Today Deutsche Bank Broadcom price target raised to $500 from $475 at Deutsche Bank 06:38 Today Mizuho Broadcom price target raised to $490 from $480 at Mizuho 06:31 Today KeyBanc Broadcom price target raised to $540 from $470 at KeyBanc AVGO Broadcom $443.23 / -19.235 (-4.16%) 03/04/21 Broadcom sees Q2 revenue approximately $6.5B, consensus $6.33B 03/04/21 Broadcom reports Q1 adjusted EPS $6.61, consensus $6.55 03/04/21 Notable companies reporting after market close 12/10/20 Broadcom sees Q1 revenue approximately $6.6B, consensus $6.52B AVGO Broadcom $443.23 / -19.235 (-4.16%) 03/04/21 Fly Intel: After-Hours Movers 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 12/11/20 Fly Intel: Wall Street's top stories for Friday 08:30 Today Broadcom - AVGO 04/05/21 Broadcom Inc. AVGO Broadcom $443.23 / -19.235 (-4.16%) 11/03/20 Unusually active option classes on open November 3rd
Recommendations	Microsoft price target raised to $290 from $285 at Morgan Stanley » 07:19 03/05/21 03/05 07:19 03/05/21 07:19 MSFT Microsoft $226.81 / -0.81 (-0.36%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MSFT Microsoft $226.81 / -0.81 (-0.36%) 03/04/21 Verb Technology readies for release of Microsoft Outlook integration 03/04/21 Schlumberger, Chevron and Microsoft collaborate on carbon negative bioenergy 03/03/21 Microsoft debuts Group Transcribe, a new Garage app for transcriptions 03/02/21 Microsoft introduces Microsoft Mesh to connect with new depth and dimension MSFT Microsoft $226.81 / -0.81 (-0.36%) 03/03/21 Citi Microsoft assumed with a Buy at Citi 02/16/21 Wedbush Microsoft price target raised to $300 from $285 at Wedbush 02/16/21 UBS Workday price target raised to $280 from $235 at UBS 02/08/21 KeyBanc Viva reinforces Microsoft Office/Teams innovation commitment, says KeyBanc MSFT Microsoft $226.81 / -0.81 (-0.36%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/26/21 Microsoft reports Q2 EPS $2.03, consensus $1.64 01/26/21 Notable companies reporting after market close 10/27/20 Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B MSFT Microsoft $226.81 / -0.81 (-0.36%) 03/04/21 Microsoft president Smith to testify at 'Big Tech' antitrust hearing, Axios says 02/28/21 Microsoft says vaccine tools have 'fallen short,' Bloomberg reports 02/23/21 Google lobbying Senate to press Microsoft on SolarWinds hack, Politico reports 02/22/21 Google hit with class-action suit over Stadia 4K promises, PCGamer says MSFT Microsoft $226.81 / -0.81 (-0.36%) 03/04/21 Fly Intel: What to watch in Slack earnings report 03/03/21 Roku upgrade, Coinbase initiation among today's top calls on Wall Street 03/02/21 Game On: GameStop CFO resigns, EA ceases new development on 'Anthem' 02/24/21 Fly Intel: What to watch in Nvidia earnings report 03/10/21 2nd Annual Enterprise Comms Virtual Summit MSFT Microsoft $226.81 / -0.81 (-0.36%) 01/26/21 Microsoft options imply 6.7% move in share price post-earnings 12/17/20 Notable open interest changes for December 17th 11/11/20 Notable open interest changes for November 11th 10/28/20 Notable open interest changes for October 28th

Recommendations	Gap price target raised to $29 from $27 at Morgan Stanley » 07:16 03/05/21 03/05 07:16 03/05/21 07:16 GPS Gap $25.43 / -0.31 (-1.20%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GPS Gap $25.43 / -0.31 (-1.20%) 03/04/21 Gap recorded $56M impairment charge in Q4 related to Intermix 03/04/21 Gap reports Q4 Old Navy Global SSS up 7% y/y 02/24/21 Gap to open distribution center in Longview, Texas 01/21/21 Gap's Athleta adds extended sizing to 350 styles in its 200 stores, online GPS Gap $25.43 / -0.31 (-1.20%) 06:48 Today Baird Gap price target raised to $29 from $25 at Baird 06:28 Today Citi Gap margins better than expected, at Citi 06:26 Today UBS Gap price target raised to $28 from $25 at UBS 02/16/21 Jefferies Gap assumed with a Hold at Jefferies GPS Gap $25.43 / -0.31 (-1.20%) 03/04/21 Gap sees FY21 EPS $1.20-$1.35, consensus $1.28 03/04/21 Gap reports Q4 EPS 61c, consensus 18c 03/04/21 Notable companies reporting after market close 11/24/20 Gap reports Q3 Old Navy SSS up 17% y/y GPS Gap $25.43 / -0.31 (-1.20%) 06:07 Today Gap CEO sees 'peacocking effect' as people emerge from Covid, WSJ reports 02/28/21 Macy's, Gap letting customers buy now, pay later, WSJ reports 12/02/20 UPS imposes shipping restrictions on Gap, Nike, WSJ reports 10/20/20 Gap reviewing options for its Gap Europe business, Bloomberg says GPS Gap $25.43 / -0.31 (-1.20%) 03/04/21 Fly Intel: After-Hours Movers 02/16/21 American Express downgrade among today's top calls on Wall Street 11/25/20 Fly Intel: Wall Street's top stories for Wednesday 11/25/20 Fly Intel: Wall Street's top stories at midday GPS Gap $25.43 / -0.31 (-1.20%) 02/02/21 Gap call volume above normal and directionally bullish 11/27/20 Notable open interest changes for November 27th 11/24/20 Gap options imply 9.2% move in share price post-earnings 11/23/20 Early notable gainers among liquid option names on November 23rd
Upgrade	NextCure upgraded to Buy from Hold at Truist » 07:14 03/05/21 03/05 07:14 03/05/21 07:14 NXTC NextCure $11.38 / -0.22 (-1.90%) Truist analyst Asthika… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings NXTC NextCure $11.38 / -0.22 (-1.90%) 01/14/21 NextCure appoints Han Myint MD as chief medical officer 12/17/20 NextCure 'working to modify' NC318 clinical program to enable trial enrollment NXTC NextCure $11.38 / -0.22 (-1.90%) 06:52 Today Truist NextCure upgraded to Buy from Hold at Truist 03/04/21 Piper Sandler NextCure price target lowered to $26 from $32 at Piper Sandler 01/15/21 BofA NextCure downgraded to Underperform on low conviction in NC318 at BofA 01/15/21 BofA NextCure downgraded to Underperform from Neutral at BofA NXTC NextCure $11.38 / -0.22 (-1.90%) 03/04/21 NextCure reports FY20 EPS ($1.33), consensus ($1.34) 11/05/20 NextCure reports Q3 EPS (59c), consensus (57c)
Recommendations	T2 Biosystems price target lowered to $1.65 from $2.40 at Alliance Global Partners » 07:13 03/05/21 03/05 07:13 03/05/21 07:13 TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 02/04/21 T2 Biosystems T2SARS-CoV can detect Brazil P.1 variant SARS-CoV 2 virus 01/11/21 T2 Biosystems: T2SARS-CoV-2 Panel can detect multiple variants of COVID-19 01/07/21 T2 Biosystems appoints Aparna Ahuja as CMO 10/19/20 Sepsis Alliance elects T2 Biosystems CEO as board member TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 01/27/21 Alliance Global Partners T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners 11/05/20 Alliance Global Partners T2 Biosystems price target raised to $2.60 from $1.65 at Alliance Global 10/07/20 BTIG T2 Biosystems initiated with a Buy at BTIG 09/30/20 JonesTrading JonesTrading reiterates $3.50 target on T2 Biosystems after BARDA contract TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 03/04/21 T2 Biosystems sees FY21 revenue $24M-$26M, consensus $33.27M 03/04/21 T2 Biosystems reports Q4 EPS (7c), consensus (7c) 01/26/21 T2 Biosystems sees FY20 revenue $18.1M, consensus $19.32M 01/26/21 T2 Biosystems sees Q4 revenue $7.8M, consensus $9.01M TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 02/05/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: After-Hours Movers 01/12/21 Fly Intel: Pre-market Movers TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 03/04/21 T2 Biosystems options imply 26.4% move in share price post-earnings 02/10/21 Largest borrow rate increases among liquid names 01/12/21 Unusually active option classes on open January 12th 10/06/20 Largest borrow rate increases among liquid names
Downgrade	Smith & Wesson Brands downgraded to Hold from Buy at Craig-Hallum » 07:12 03/05/21 03/05 07:12 03/05/21 07:12 SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) Craig-Hallum analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 03/04/21 Smith & Wesson Brands jumps 5% to $16.64 after Q3 results beat estimates 03/04/21 Smith & Wesson Brands reports Q3 gross margin 42.6% vs. 28% last year 03/04/21 Smith & Wesson Brands announces $100M share repurchase plan 03/03/21 FBI reports 3.44M NICS firearm background checks in February SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 03/04/21 B. Riley Securities B. Riley starts American Outdoor Brands with Buy, $32 price target 12/04/20 Lake Street Lake Street ups Smith & Wesson Brands price target to $28 after earnings 10/05/20 B. Riley Securities Firearm demand has seen meaningful uptick, says B. Riley Securities 09/24/20 Fly Intel: Top five analyst initiations SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 03/04/21 Smith & Wesson Brands reports Q3 EPS $1.12, consensus 76c 12/03/20 Smith & Wesson Brands reports Q2 adjusted EPS 93c, consensus 63c SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 12/15/20 Smith & Wesson sues New Jersey to block subpoena related to marketing, WSJ says SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 03/04/21 Fly Intel: After-Hours Movers 12/16/20 Fly Intel: After-Hours Movers 12/03/20 Fly Intel: After-Hours Movers SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 02/18/21 Smith and Wesson call volume above normal and directionally bullish 02/03/21 Smith and Wesson put volume heavy and directionally bearish 01/27/21 Smith and Wesson put volume heavy and directionally bearish 01/11/21 Smith and Wesson call volume above normal and directionally bullish
Earnings	LifeMD sees Q1 revenue exceeding $17M, up over 295% vs. last year » 07:12 03/05/21 03/05 07:12 03/05/21 07:12 LFMD LifeMD $14.36 / -1.91 (-11.74%) LifeMD expects revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Options LFMD LifeMD $14.36 / -1.91 (-11.74%) 02/22/21 Conversion Labs to begin trading as LifeMD LFMD LifeMD $14.36 / -1.91 (-11.74%) 02/22/21 One new option listing and ten option delistings on February 22nd

Recommendations	Dyne Therapeutics weakness a buying opportunity, says Stifel » 07:11 03/05/21 03/05 07:11 03/05/21 07:11 DYN Dyne Therapeutics $15.77 / -0.97 (-5.79%) Stifel analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly DYN Dyne Therapeutics $15.77 / -0.97 (-5.79%) 03/04/21 Dyne Therapeutics expects cash to fund requirements into 2H24 03/04/21 Dyne Therapeutics appoints Wildon Farwell as CMO 02/08/21 Dyne Therapeutics appoints Ashish Dugar as SVP, global head of medical affairs 01/10/21 Dyne Therapeutics announced new preclinical data from DM1 program DYN Dyne Therapeutics $15.77 / -0.97 (-5.79%) 02/09/21 Dyne Therapeutics initiated with a Buy at JonesTrading 01/07/21 Piper Sandler Dyne Therapeutics potential beneficiary of Sarepta's SRP-9001 miss, says Piper 10/12/20 Jefferies Dyne Therapeutics initiated with a Buy at Jefferies 10/12/20 JPMorgan Dyne Therapeutics initiated with an Overweight at JPMorgan DYN Dyne Therapeutics $15.77 / -0.97 (-5.79%) 03/04/21 Dyne Therapeutics reports Q4 EPS (64c), consensus (37c) 11/05/20 Dyne Therapeutics reports Q3 EPS ($2.01), consensus (87c) 21 Jan 17 Sep DYN Dyne Therapeutics $15.77 / -0.97 (-5.79%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 09/28/20 Fly Intel: After-Hours Movers 09/20/20 Opening Day: Snowflake shares double in biggest software IPO ever
Initiation	Saratoga Investment initiated with an Outperform at Hovde Group » 07:11 03/05/21 03/05 07:11 03/05/21 07:11 SAR Saratoga Investment $22.85 / -0.24 (-1.04%) Hovde Group analyst Bryce… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SAR Saratoga Investment $22.85 / -0.24 (-1.04%) 01/06/21 Saratoga Investment increases quarterly cash dividend to 42c per share 10/07/20 Saratoga Investment increases quarterly dividend by 1c to 41c per share SAR Saratoga Investment $22.85 / -0.24 (-1.04%) 01/07/21 Ladenburg Saratoga Investment price target raised to $25 from $21 at Ladenburg 01/07/21 Janney Montgomery Scott Saratoga Investment upgraded to Buy from Neutral at Janney Montgomery Scott 07/13/20 Compass Point Saratoga Investment price target raised to $19.75 from $16.50 at Compass Point SAR Saratoga Investment $22.85 / -0.24 (-1.04%) 01/06/21 Saratoga Investment reports Q3 adjusted EPS 50c, consensus 47c 10/07/20 Saratoga Investment reports Q2 adj. EPS 49c, consensus 26c
Initiation	Oaktree Specialty Lending initiated with an Outperform at Hovde Group » 07:11 03/05/21 03/05 07:11 03/05/21 07:11 OCSL Oaktree Specialty Lending / + Hovde Group analyst Bryce… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events OCSL Oaktree Specialty Lending / + 11/19/20 Oaktree Specialty Lending raises quarterly cash distribution to 11c per share 10/29/20 Oaktree Specialty Lending, Oaktree Strategic Income enter merger agreement OCSL Oaktree Specialty Lending / + 06/19/20 Janney Montgomery Scott Oaktree Specialty Lending upgraded to Buy at Janney Montgomery Scott 06/19/20 Janney Montgomery Scott Oaktree Specialty Lending upgraded to Buy from Neutral at Janney Montgomery Scott 03/05/20 National Securities Oaktree Specialty Lending initiated with a Buy at National Securities OCSL Oaktree Specialty Lending / + 11/19/20 Oaktree Specialty Lending reports Q4 adjusted NII 17c, consensus 12c 03/15/21 Oaktree Specialty Lending Corp
Initiation	New Mountain Finance initiated with a Market Perform at Hovde Group » 07:10 03/05/21 03/05 07:10 03/05/21 07:10 NMFC New Mountain Finance $12.58 / -0.315 (-2.44%) Hovde Group analyst Bryce… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings NMFC New Mountain Finance $12.58 / -0.315 (-2.44%) 01/04/21 New Mountain Finance extends share repurchase program NMFC New Mountain Finance $12.58 / -0.315 (-2.44%) 08/10/20 National Securities New Mountain Finance downgraded to Neutral from Buy at National Securities 03/17/20 National Securities New Mountain Finance upgraded to Buy from Neutral at National Securities 03/05/20 National Securities New Mountain Finance initiated with a Neutral at National Securities NMFC New Mountain Finance $12.58 / -0.315 (-2.44%) 02/24/21 New Mountain Finance reports Q4 NII 30c, consensus 30c 11/04/20 New Mountain Finance reports Q3 adjusted NII 30c, consensus 30c
Hot Stocks	Imara to initiate pediatric clinical program of IMR-687 in 1H21 » 07:10 03/05/21 03/05 07:10 03/05/21 07:10 IMRA Imara $12.37 / -0.8 (-6.07%) Imara anticipates… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events IMRA Imara $12.37 / -0.8 (-6.07%) 07:09 Today Imara plans to report interim data from Phase 2b IMR-687 trials in 2H21 07:08 Today Imara reports Phase 2a open label extension clinical trial data 07:02 Today Imara expects cash to fund planned operations into mid-2022 01/20/21 Imara appoints Kenneth Atttie as Chief Medical Officer IMRA Imara $12.37 / -0.8 (-6.07%) 01/06/21 SVB Leerink Imara selloff a potential buying opportunity, says SVB Leerink 08/17/20 Fly Intel: Top five analyst upgrades 08/17/20 Citi Imara upgraded to Buy from Neutral at Citi 06/30/20 Citi Imara downgraded to Neutral from Buy at Citi IMRA Imara $12.37 / -0.8 (-6.07%) 07:02 Today Imara reports 2020 EPS ($3.53), consensus ($3.82) 11/05/20 Imara reports Q3 EPS (72c), consensus (80c) 12 Mar IMRA Imara $12.37 / -0.8 (-6.07%) 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 01/06/21 Fly Intel: Wall Street's top stories at midday 03/16/21 Healthcare Corporate Access Virtual Day 03/16/21 Healthcare Corporate Access Virtual Day 08:30 Today Imara - IMRA

Hot Stocks	Imara plans to report interim data from Phase 2b IMR-687 trials in 2H21 » 07:09 03/05/21 03/05 07:09 03/05/21 07:09 IMRA Imara $12.37 / -0.8 (-6.07%) Imara plans to report… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events IMRA Imara $12.37 / -0.8 (-6.07%) 07:08 Today Imara reports Phase 2a open label extension clinical trial data 07:02 Today Imara expects cash to fund planned operations into mid-2022 01/20/21 Imara appoints Kenneth Atttie as Chief Medical Officer 01/06/21 Imara reports Phase 2a trial results of IMR-687 in SCD IMRA Imara $12.37 / -0.8 (-6.07%) 01/06/21 SVB Leerink Imara selloff a potential buying opportunity, says SVB Leerink 08/17/20 Fly Intel: Top five analyst upgrades 08/17/20 Citi Imara upgraded to Buy from Neutral at Citi 06/30/20 Citi Imara downgraded to Neutral from Buy at Citi IMRA Imara $12.37 / -0.8 (-6.07%) 07:02 Today Imara reports 2020 EPS ($3.53), consensus ($3.82) 11/05/20 Imara reports Q3 EPS (72c), consensus (80c) 12 Mar IMRA Imara $12.37 / -0.8 (-6.07%) 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 01/06/21 Fly Intel: Wall Street's top stories at midday 03/16/21 Healthcare Corporate Access Virtual Day 03/16/21 Healthcare Corporate Access Virtual Day 08:30 Today Imara - IMRA
Hot Stocks	Can-Fite BioPharma enrolls first patient in Phase II COVID-19 study » 07:09 03/05/21 03/05 07:09 03/05/21 07:09 CANF Can-Fite BioPharma $1.81 / -0.14 (-7.20%) Can-Fite BioPharma… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News CANF Can-Fite BioPharma $1.81 / -0.14 (-7.20%) 02/22/21 Can-Fite BioPharma announces data from the Phase II advanced liver cancer study 01/08/21 Can-Fite BioPharma announces Namodenoson study published 12/15/20 Can-Fite receives Israel Ministry of Health approval to study cannabinoids 12/14/20 Can-Fite BioPharma updates prgress with Namodenoson candidate in NAFLD
Hot Stocks	Imara reports Phase 2a open label extension clinical trial data » 07:08 03/05/21 03/05 07:08 03/05/21 07:08 IMRA Imara $12.37 / -0.8 (-6.07%) Imara conducted a review… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events IMRA Imara $12.37 / -0.8 (-6.07%) 07:02 Today Imara expects cash to fund planned operations into mid-2022 01/20/21 Imara appoints Kenneth Atttie as Chief Medical Officer 01/06/21 Imara reports Phase 2a trial results of IMR-687 in SCD 12/07/20 Imara presents IMR-687 Phase 2a OLE case reports IMRA Imara $12.37 / -0.8 (-6.07%) 01/06/21 SVB Leerink Imara selloff a potential buying opportunity, says SVB Leerink 08/17/20 Fly Intel: Top five analyst upgrades 08/17/20 Citi Imara upgraded to Buy from Neutral at Citi 06/30/20 Citi Imara downgraded to Neutral from Buy at Citi IMRA Imara $12.37 / -0.8 (-6.07%) 07:02 Today Imara reports 2020 EPS ($3.53), consensus ($3.82) 11/05/20 Imara reports Q3 EPS (72c), consensus (80c) 12 Mar IMRA Imara $12.37 / -0.8 (-6.07%) 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 01/06/21 Fly Intel: Wall Street's top stories at midday 03/16/21 Healthcare Corporate Access Virtual Day 03/16/21 Healthcare Corporate Access Virtual Day 08:30 Today Imara - IMRA
Recommendations	Tidal is an 'excellent fit' for Square, says Mizuho » 07:08 03/05/21 03/05 07:08 03/05/21 07:08 SQ Square $218.43 / -15.71 (-6.71%) Mizuho analyst Dan Dolev… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SQ Square $218.43 / -15.71 (-6.71%) 03/04/21 Square director sells 8.2K shares of common stock 03/04/21 Square to acquire majority stake in Tidal for $297M in cash, stock 03/01/21 Square says Square Financial Services has begun operations 02/23/21 Square slips over 4% to about $245 after Q4 results SQ Square $218.43 / -15.71 (-6.71%) 07:04 Today Citi Square stake in Tidal could be large 'flywheel enhancer,' says Citi 03/04/21 BTIG Square purchase of Tidal stake looks like 'NFT play,' says BTIG 03/03/21 MoffettNathanson MoffettNathanson says Square gross profit can grow at over 35% CAGR through 2023 02/25/21 Fly Intel: Top five analyst upgrades SQ Square $218.43 / -15.71 (-6.71%) 02/23/21 Square reports Q4 adjusted EPS 32c, consensus 24c 02/23/21 Notable companies reporting after market close 11/05/20 Square reports Q3 adjusted EPS 34c, consensus 16c 11/05/20 Square reports Q3 revenue $3.03B, consensus $2.07B SQ Square $218.43 / -15.71 (-6.71%) 02/24/21 Square CFO says Cash App saw surge in new bitcoin buyers in January, CNBC says 02/19/21 'Heard on the Street' highlights PayPal, Square among crypto-exposure names 12/24/20 Square held talks to acquire music service Tidal, Bloomberg reports 11/25/20 DOJ wants Intuit to sell Credit Karma tax unit to approve deal, CNBC says SQ Square $218.43 / -15.71 (-6.71%) 03/04/21 Fly Intel: Wall Street's top stories for Thursday 03/04/21 Fly Intel: Wall Street's top stories at midday 02/26/21 The Intersection: Crypto and Wall Street This Week 02/25/21 Lowe's, Square upgrades among today's top calls on Wall Street SQ Square $218.43 / -15.71 (-6.71%) 03/02/21 Square call volume above normal and directionally bullish 02/23/21 Square options imply 13.4% move in share price post-earnings 12/22/20 Unusual call flow in option market yesterday 12/21/20 Upside call seller takes advantage of all-time high in Square
Hot Stocks	NewAge appoints Carin Casso Reinhardt as CPO » 07:07 03/05/21 03/05 07:07 03/05/21 07:07 NBEV NewAge $2.66 / -0.155 (-5.51%) NewAge announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NBEV NewAge $2.66 / -0.155 (-5.51%) 03/04/21 NewAge enters LOI to acquire Japan-based Aliven for approx. 1M shares 02/16/21 NewAge announces $58M private placement 12/01/20 NewAge announces $30M debt facility 11/19/20 NewAge appoints Fred Cooper to board of directors NBEV NewAge $2.66 / -0.155 (-5.51%) 03/04/21 Roth Capital NewAge's LOI to acquire Aliven strengthens Buy thesis, says Roth Capital 07/21/20 Alliance Global Partners New Age Beverages price target raised to $5 from $3.50 at Alliance Global 04/14/20 Alliance Global Partners New Age Beverages at Alliance Global Partners 03/11/20 Compass Point New Age Beverages price target lowered to $4 from $9 at Compass Point NBEV NewAge $2.66 / -0.155 (-5.51%) 02/16/21 NewAge ses Q4 net revenue in $90M range, consensus $79.34M 11/09/20 NewAge reports Q3 EPS (14c), consensus (6c) NBEV NewAge $2.66 / -0.155 (-5.51%) 11/09/20 Fly Intel: Pre-market Movers 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 NewAge - NBEV

Downgrade	Comerica downgraded to Neutral from Buy at B. Riley Securities » 07:07 03/05/21 03/05 07:07 03/05/21 07:07 CMA Comerica $68.29 / -1.56 (-2.23%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options CMA Comerica $68.29 / -1.56 (-2.23%) 02/17/21 Comerica temporarily closes Texas banking centers, offices due to weather 02/16/21 Comerica announces temporary closure of many locations CMA Comerica $68.29 / -1.56 (-2.23%) 01/20/21 DA Davidson Comerica price target raised to $62 from $50 at DA Davidson 01/20/21 Truist Comerica price target raised to $67 from $56 at Truist 01/20/21 B. Riley Securities Comerica price target raised to $72 from $65 at B. Riley Securities 01/14/21 Raymond James Comerica upgraded to Outperform from Market Perform at Raymond James CMA Comerica $68.29 / -1.56 (-2.23%) 01/19/21 Comerica reports Q4 EPS $1.49, consensus $1.19 10/20/20 Comerica reports Q3 EPS $1.44, consensus 83c 03/15/21 Virtual Atlanta and Texas Bank Summit 04/20/21 Comerica - CMA CMA Comerica $68.29 / -1.56 (-2.23%) 10/20/20 Early notable gainers among liquid option names on October 20th
Hot Stocks	Investor group issues letter to Kohl's shareholders regarding Q4 earnings » 07:07 03/05/21 03/05 07:07 03/05/21 07:07 KSS Kohl's $54.75 / -2.925 (-5.07%) Macellum Advisors, Ancora… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options KSS Kohl's $54.75 / -2.925 (-5.07%) 03/02/21 Kohl's planning $200M-$300M in share repurchases in 2021 03/02/21 Kohl's plans to refresh approximately 675 stores over the next two years 03/02/21 Kohl's 'optimistic that brighter days are ahead' 03/02/21 Kohl's 'confident' in ability to expand operating margin to 7%-8% by 2023 KSS Kohl's $54.75 / -2.925 (-5.07%) 06:29 Today UBS Kohl's price target raised to $54 from $50 at UBS 03/03/21 Credit Suisse Kohl's price target raised to $58 from $30 at Credit Suisse 03/03/21 Cowen Kohl's price target raised to $67 from $65 at Cowen 03/03/21 Citi Kohl's price target raised to $67 from $56 at Citi KSS Kohl's $54.75 / -2.925 (-5.07%) 03/02/21 Kohl's sees FY21 EPS $2.45-$2.95, consensus ($2.43) 03/01/21 Notable companies reporting before tomorrow's open 03/01/21 Notable companies reporting before tomorrow's open 02/04/21 Kohl's reports preliminary Q4 EPS $1.00-$1.05, consensus 70c KSS Kohl's $54.75 / -2.925 (-5.07%) 02/22/21 Kohl's 'rejects' activist investor group attempt in statement to CNBC 02/21/21 Nine directors nominated to Kohl's board by activist investors, WSJ reports 09/21/20 Walmart to launch private label for men's and women's clothing, CNBC reports KSS Kohl's $54.75 / -2.925 (-5.07%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Fly Intel: Pre-market Movers 02/22/21 Fly Intel: Wall Street's top stories for Monday KSS Kohl's $54.75 / -2.925 (-5.07%) 01/11/21 Early notable gainers among liquid option names on January 11th 12/30/20 Early notable gainers among liquid option names on December 30th 12/18/20 Early notable gainers among liquid option names on December 18th 12/11/20 Kohl's put volume heavy and directionally bearish
Downgrade	Caterpillar downgraded to Neutral from Outperform at Daiwa » 07:05 03/05/21 03/05 07:05 03/05/21 07:05 CAT Caterpillar $212.57 / -2.32 (-1.08%) Daiwa analyst Jairam… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CAT Caterpillar $212.57 / -2.32 (-1.08%) 02/25/21 Caterpillar elects Gerald Johnson to board of directors 02/02/21 Caterpillar completes acquisition of Weir Oil & Gas, launches SPM Oil & Gas 01/29/21 Caterpillar says sees strength in base metals mining 01/29/21 Caterpillar says 'hard to quantify' improvement in 2021 vs. 2020 CAT Caterpillar $212.57 / -2.32 (-1.08%) 02/25/21 JPMorgan Caterpillar price target raised to $237 from $205 at JPMorgan 02/10/21 Baird Baird remains bullish on Caterpillar, sees positive read through from Finning Q4 02/01/21 BMO Capital Caterpillar price target raised to $190 from $135 at BMO Capital 02/01/21 Credit Suisse Caterpillar price target raised to $235 from $228 at Credit Suisse CAT Caterpillar $212.57 / -2.32 (-1.08%) 01/29/21 Caterpillar reports Q4 adjusted EPS $2.12, consensus $1.49 01/28/21 Notable companies reporting before tomorrow's open 01/28/21 Notable companies reporting before tomorrow's open 10/27/20 Caterpillar says not providing FY21 guidance CAT Caterpillar $212.57 / -2.32 (-1.08%) 11/18/20 DOJ agents told to halt further action in Caterpillar case in 2018, Reuters says CAT Caterpillar $212.57 / -2.32 (-1.08%) 01/29/21 Fly Intel: Pre-market Movers 12/30/20 AstraZeneca upgrade, Spotify target change among top calls on Wall Street 10/27/20 Fly Intel: Wall Street's top stories for Tuesday 10/27/20 Fly Intel: Wall Street's top stories at midday CAT Caterpillar $212.57 / -2.32 (-1.08%) 02/24/21 Caterpillar call volume above normal and directionally bullish 12/30/20 Caterpillar call volume above normal and directionally bullish 12/30/20 Unusually active option classes on open December 30th 10/27/20 Unusually active option classes on open October 27th
Syndicate	Federated National files to sell common stock, no amount given » 07:04 03/05/21 03/05 07:04 03/05/21 07:04 FNHC Federated National $6.73 / +0.405 (+6.40%) Piper Sandler & Co.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings FNHC Federated National $6.73 / +0.405 (+6.40%) 11/04/20 Federated National forms strategic review committee FNHC Federated National $6.73 / +0.405 (+6.40%) 11/06/20 Raymond James Federated National downgraded to Market Perform from Outperform at Raymond James 11/06/20 Raymond James Federated National downgraded to Market Perform from Outperform at Raymond James 07/21/20 Raymond James Federated National downgraded at Raymond James amid looming hurricane season 07/21/20 Raymond James Federated National downgraded to Outperform from Strong Buy at Raymond James FNHC Federated National $6.73 / +0.405 (+6.40%) 03/02/21 Federated National reports Q4 EPS ($1.96), consensus ($2.65) 11/04/20 Federated National reports Q3 EPS ($1.57), consensus ($1.37)
Recommendations	Veritone price target raised to $50 from $42 at Roth Capital » 07:04 03/05/21 03/05 07:04 03/05/21 07:04 VERI Veritone / + Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options VERI Veritone / + 02/09/21 Veritone continues international expansion through agreement with Peru's CRP Rad 01/19/21 Veritone, Base Media Cloud announce six-year agreement 01/11/21 Veritone announces strategic relationship with Alteryx 12/09/20 Veritone enters new content licensing agreement with Brave Bison VERI Veritone / + 06:10 Today JMP Securities Veritone price target raised to $45 from $21 at JMP Securities 02/23/21 Roth Capital Veritone price target raised to $42 from $31 at Roth Capital 12/21/20 Roth Capital Veritone price target raised to $31 from $20 at Roth Capital 12/21/20 Stifel Veritone initiated with a Hold at Stifel VERI Veritone / + 03/04/21 Veritone sees FY21 revenue $76M-$81M, consensus $68.3M 03/04/21 Veritone sees Q1 revenue $17M-$17.5M, consensus $15.41M 03/04/21 Veritone reports Q4 adjusted EPS (14c), consensus (15c) 11/09/20 Veritone sees Q4 revenue $16M-$16.4M, consensus $14.95M 03 Dec VERI Veritone / + 12/02/20 Fly Intel: After-Hours Movers 11/09/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference VERI Veritone / + 12/07/20 Largest borrow rate increases among liquid names

Events

Earnings calls, analyst events, roadshows and more

GSX
Today at 08:00

GSX Techedu - GSX Conference Calls
BIG
Today at 08:00

Big Lots - BIG Conference Calls
COE
Today at 08:00

China Online Education - COE Conference Calls
IVA
Today at 08:00

Inventiva - IVA Conference Calls
CLLS
Today at 08:00

Cellectis - CLLS Conference Calls
EGLE
Today at 08:00

Eagle Bulk Shipping - EGLE Conference Calls
Today at 08:00

European Capital Goods Industry Meetings
Today at 08:30

Employment Situation: Non-Farm Payrolls M/M: February 2021 Government Event
Today at 08:30

Employment Situation--Average Hourly Earnings Y/Y: February 2021 Government Event
Today at 08:30

Employment Situation--Unemployment Rate: February 2021 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan Priced at: $46.50 3.9M Shares INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan Priced at: $73.25 4.65M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham Priced at: $31.00 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital Priced at: $140.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRC X AMRC Ameresco Spot Secondary Managers: BofA & Oppenheimer, Baird, Canaccord, Guggenheim, William Blair Priced at: $44.00 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

L Brands falls -20.6%

TODAY'S FREE FLY STORIES

Get Full Fly Access